trial · primary record
KK-LC-1 TCR-T cells
Gastric Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Maximum tolerated dose (MTD) of KK-LC-1 TCR-T cells |
| Registry ID | NCT05483491 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:43:01.116Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05483491
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.